Connect with us

Business Wire

Wellbeing Subsidiary KGK Science Announces Successful Delivery of CBD and THC Through the Skin of Healthy Volunteers

Published

on


Gefion Canada GT4 technology was used to deliver cannabidiol (CBD) and tetrahydrocannabinol (THC) to healthy volunteers in the form of a topical cream applied to the skin

VANCOUVER, British Columbia–(BUSINESS WIRE)–$KONEF #psychedelics–Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announced today that its wholly owned subsidiary KGK Science Inc. (“KGK”), completed an open label study, where Gefion Canada (“Gefion”) GT4 technology was used to successfully deliver cannabidiol (CBD) and tetrahydrocannabinol (THC) to healthy volunteers in the form of a topical cream applied to the skin.

Gefion GT4 technology uses novel penetrating agents to transport CBD and THC through the skin and directly into the blood. Transdermal delivery of topically-applied cannabinoids can be difficult and prior to this study, published research demonstrating successful topical delivery did not exist. The Gefion Canada study, published in Advances in Therapy, showed for the first time that CBD and THC were successfully transported into the blood stream following application to the skin. Gefion GT4 technology may provide lower, more steady-state cannabinoid concentrations that minimize psychoactive effects in participants. These findings present a potential benefit in the treatment of chronic conditions over longer periods of time, or in the treatment of diseases where high concentrations of cannabinoids are needed in relation to the body weight of vulnerable populations such as pediatrics.

Importantly, CBD and THC delivery in this study was found to be safe and well tolerated by all participants. None of the volunteers experienced any intoxicating effects. Topical cannabis may provide the benefit of extended cannabinoid delivery without the worry of intoxication, suggesting it may be beneficial for certain lifestyles and therapeutic indications. However, more research is needed.

“This study represents an important step forward in cannabis research. This study opens the door for future double-blind, placebo-controlled trials to further investigate topical cannabis delivery,” says Dr. Erin D. Lewis, Scientific Director at KGK Science.

ABOUT GEFION

Gefion is a specialty pharmaceutical company whose mission is to utilize its technological, regulatory and commercial advantages to market cannabinoid prescription products in the United States, Canada and Europe focusing on established markets with predicate products and insurance reimbursement. It is developing GT4 CBD for the treatment of epilepsy in children.

ABOUT KGK SCIENCE

Subsidiary of Wellbeing Digital Sciences, KGK is a leading North American contract research organization based in London, Ontario that primarily provides high-quality clinical research trials with a focus on nutraceutical and emerging health care products. Founded in 1997, the business has successfully helped hundreds of companies with custom designed clinical trials and claim substantiation strategies to move products into global markets. KGK’s other existing service lines include expert regulatory support and compliance solutions, participant recruitment, research support services and consulting services. Furthermore, the company has produced over 150 publications, executed over 400 clinical trials across more than 40 indications, amassed 25,000 participants in its database and collected 10 million data points. For additional information, please visit kgkscience.com.

ABOUT WELLBEING DIGITAL SCIENCES

Wellbeing Digital Sciences Inc. is an evidence-based mental healthcare company focused on the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. Its mission is supported by a network of North American clinics that provide forward-thinking therapies and other types of treatment to patients as well as through a contract research organization that offers clinical trials services to clients pursuing drug development. For additional information, please visit wellbeingdigital.co.

On behalf of:

Najla Guthrie

Chief Executive Officer

WELLBEING DIGITAL SCIENCES

Notice Regarding Forward-Looking Information:

This news release contains forward-looking statements including but not limited to statements regarding the Company’s business, assets or investments, as well other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, investor interest in the business and prospects of the Company.

The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.

Contacts

Natalie Dolphin
VP of Marketing & Investment Relations

Email: ndolphin@wellbeingdigital.co
Twitter: @Wellbeing_IR

This post was originally published on this site





Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business Wire

Global Pet Food Ingredients Market Analysis Report 2022-2027: Shift in Focus Toward Natural and Grain-Free Products & Increasing Trend of Pet Humanization to Drive Demand for Premium Pet Products – ResearchAndMarkets.com

Published

on

By


DUBLIN–(BUSINESS WIRE)–The “Global Pet Food Ingredients Market by Ingredient (Meat & Meat Products, Cereals, Vegetables & Fruits, Fats, Additives), Source (Animal-based, Plant Derivatives, Synthetic), Pet (Dogs, Cats, Fish), Form, and Region – Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.

The global pet food ingredients market is estimated to be valued at USD 32.2 billion in 2022. It is projected to reach USD 44.5 billion by 2027, with a CAGR of 6.7%

The market is gaining momentum as pet food ingredients continue to find increased applications across various pet species such as dogs, cats, fish and other pets such as rabbits, birds and horses. The demand for pet food ingredients is gaining significant traction in the industry, especially due to the rising focus of owners on the health and nutrition of pet animals in recent years.

Additionally, the rising innovation in the pet food ingredients market and technological advancements which are enhancing the efficiency of pet food ingredients have contributed to the growth of the market in recent years.

By ingredient, meat & meat products segment occupies the highest market share during the forecast period

Based on ingredient, meat & meat products accounted for the highest market share among all other segments owing to their rich taste and nutrition profile owing to which they have high acceptability rate among pet animals.

Meat & meat products are also effective in supporting the gut health of pets due to their higher amino acid content which is effective in controlling infections and inhibition of growth of pathogens and bacteria. Due to their high acceptability rate among pets, rich nutrition profile and desirable health benefits, they are highly preferred by pet owners, contributing to their increased demand.

By pet, dog segment is forecasted to account for the dominant segment during the forecasted period

Based on pet, the dog segment accounts for the highest market share. Dogs offer an attractive market for manufacturers of pet food ingredients owing to their varied nutritional requirements, compared to other pet animals.

A significant number of additives such as vitamins, minerals and enzymes are added to dog food products to satisfy their nutritional requirements. Dogs also account among the most preferred pets among owners, having a healthy adoption rate around the world which presents significant business opportunities for manufacturers of pet food ingredients.

By source, animal-based pet food ingredients are expected to retain their position as the dominant segment over the forecast period

Based on source, the animal-based segment is expected to account for the largest and fastest-growing segment over the forecast period because of the increasing demand among pet owners owing to their large health benefits and increased acceptability among pet animals.

They are associated with a range of health benefits such as enhancement of health of skin and coat of pet animals and are also considered effective in the inhibition and growth of pathogen and controlling infections such as bladder stones and urinary tract infections, which contributes to their increased demand in the industry.

By form, the dry segment is expected to retain its position as the dominant segment over the forecast period

Based on form, the dry segment is likely to account for the dominant and the fastest growing segment over the forecasted period.

The dry form of pet food ingredients are associated with a range of desirable characteristics such as having a richer nutritional profile, along with being highly cost-effective as compared to liquid form of pet food ingredients. They also offer higher convenience of handling during processing and storage owing to their lower moisture content which is also likely to drive their demand over the forecasted period.

The North America region accounts for the dominant market share for the pet food ingredients market during the forecast period

North America region is expected to retain its position as the dominant region for pet food ingredients market during the forecasted period.

The region’s large market share is attributed to a variety of reasons such as increase in adoption of pet animals owing to the rising pet humanization trend in the region. The pet owners in the region demonstrate a high level of awareness regarding health and nutrition of their pets, which contributes to the higher demand of pet food ingredients in the region.

The region’s growth has also been bolstered due to the presence of a significant number of major pet food ingredients manufacturing companies. The US, one of the North American countries, also accounts among the leading pet food ingredient producers, and has a large pet population which has also significantly contributed towards the growth of pet food ingredients industry in the region.

Competitive landscape

Key players in this market include BASF SE (Germany), Darling Ingredients Inc. (US), Cargill (US), Ingredion (US), DSM (Netherlands), Omega Protein Corporation (US), ADM (US), Kemin Industries, Inc. (US), Chr. Hansen Holding A/S (Denmark), and Roquette Freres (France).

Premium Insights

  • Increasing Adoption of Pets and Rising Pet Humanization Trend to Propel Growth
  • US and Animal-based Accounted for the Largest Shares in North American Market in 2021
  • Dogs Segment to Dominate During Forecast Period
  • Dry Segment to Dominate During Forecast Period
  • North America to Dominate During Forecast Period
  • Meat & Meat Products to Dominate During Forecast Period

Market Overview

Macroeconomic Factors

  • Rising Pet Adoption Among Urban Population
  • Increasing Trend of Pet Humanization to Drive Demand for Premium Pet Products

Drivers

  • Increase in Pet Expenditure with Substantial Rise in Pet Food Expenditure
  • Switch from Mass Products to Organic Pet Food Ingredients
  • Acceptance of Insect-based Protein and Oils by Pet Owners

Restraints

  • Non-Uniformity of Regulations Hindering International Trade
  • Limited Availability of Ingredients and Price Sensitivity

Opportunities

  • Use of Cannabis in Pet Food
  • Technological Advancements to Enhance Product Development
  • Shift in Focus Toward Natural and Grain-Free Products

Challenges

  • Capital Investment for Equipment
  • Threat from Counterfeit Products

Value Chain

  • Research and Product Development
  • Raw Material Sourcing
  • Production and Processing
  • Distribution
  • Marketing & Sales

Company Profiles

Key Players

  • BASF SE
  • Darling Ingredients Inc.
  • Cargill
  • Ingredion
  • DSM
  • Omega Protein Corporation
  • ADM
  • Kemin Industries, Inc.
  • Chr. Hansen Holding A/S
  • Roquette Freres

Other Players

  • Saria A/S GmbH & Co. KG
  • The Scoular Company
  • Lallemand Inc.
  • Phileo by Lesaffre
  • Labudde Group Inc.
  • Linkone Ingredient Solutions
  • 3D Corporate Solutions
  • Hydrite Chemical
  • Green Source Organics
  • Biorigin
  • Vitiva D.O.O.
  • AFB International
  • Symrise
  • Mowi ASA
  • Zinpro Corp.

For more information about this report visit https://www.researchandmarkets.com/r/8y915n

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

This post was originally published on this site



Source link

Continue Reading

Business Wire

Wedbush Securities’ Senior Vice President, Equity Research, Gerald, Pascarelli, CFA® Initiates Coverage on U.S. Cannabis Names CRLBF, CURLF, GTBIF & TCNNF

Published

on

By


 

LOS ANGELES–(BUSINESS WIRE)–Wedbush Securities, one of the nation’s leading independent diversified financial services providers, is pleased to announce that Equity Research Analyst, Gerald Pascarelli, CFA® is launching coverage in the U.S. Cannabis sector. On the heels of his initiation on 11 stocks in the Non-Alcoholic and Alcoholic Beverages sectors in October 2022, Gerald will expand to cover four stocks within the cannabis space: Cresco Labs Inc. (CRLBF), Curaleaf Holdings, Inc. (CURLF), Green Thumb Industries, Inc. (GTBIF) and Trulieve Cannabis Corp. (TCNNF). This initiation represents an extension into an area that was not covered by Wedbush, further expanding the scope of coverage of the firm’s Equity Research team.


Prior to joining Wedbush, Gerald served as VP of Equity Research at Cowen, Inc., where he covered both the alcoholic and non-alcoholic beverage sectors for eight years and was also an integral part of the firm’s coverage launch into the cannabis sector in 2016. In his previous role, Gerald contributed to several research white papers and cross-category consumer reports, focused on market sizing, consumer demographics and cannabis’ impact on alcoholic beverages. Prior to Cowen, Gerald spent eight years at Kingdon Capital Management, a New York-based hedge fund. He states, “As we near the end of 2022, we believe that brighter days lie ahead for the U.S. cannabis industry. I look forward to developing this new vertical of research here at Wedbush and am compelled by the current risk/reward setup for this sector of the market.”

Kevin Merritt, Wedbush Securities’ Director of Research says, “We are thrilled to have Gerald initiating in the Cannabis space as it heralds a new area of growth for our Equity Research team. As we tap into this never-before-covered space for the firm, Gerald and his team are the perfect fit to champion this new effort.”

Gerald received his Bachelor’s degree in Business Administration with a concentration in Finance from the State University of New York, at Albany. He is also a CFA® charterholder.

About Wedbush Securities

Wedbush Securities is the largest subsidiary of Wedbush Financial Services. Since its founding in 1955, Wedbush has been a leader in the financial services industry, providing our clients, both private and institutional, with a wide range of securities brokerage, wealth management, and investment banking services. Headquartered in Los Angeles, California with 100 registered offices and nearly 900 colleagues, the firm focuses on client service and financial safety, innovation, and the utilization of advanced technology.

Follow Us:

Wedbush Twitter
Wedbush Facebook

Wedbush LinkedIn
Wedbush Instagram

Contacts

Natalie A. Svider

213-688-8057

publicrelations@wedbush.com

This post was originally published on this site





Source link

Continue Reading

Business Wire

WeighPack Introduces High Precision Check Weigher for Tightest Tolerances

Published

on

By


LAS VEGAS–(BUSINESS WIRE)–#automation–WeighPack Systems’ WeightCheQ 0-250 features high precision electromagnetic force restoration (EMFR) weigh cell technology to achieve the highest tolerances possible while reading in three decimal points.


The WeightCheQ 0-250 is engineered with a weight range of 0 – 250 grams and will weigh product accurately and consistently to +/- 0.01 gram. This tight tolerance level makes it the perfect choice for check weighing pharmaceuticals, cosmetics, precious metals, cannabis pre-rolls and more.

This high-performance weigher will automatically reject product that is outside of the user’s set tolerance level and deposit it into a convenient accumulation drawer for reuse. An easy-to-read visual operation interface notifies the user when product is within the targeted weight by illuminating a green light and then changing to a red light when the target weight is out of tolerance.

The 0-250 includes a large color touchscreen, does not require compressed air and easily integrates into existing packaging lines for an immediate improvement in any quality assurance process.

This compact, modular check weigher also features heavy-duty stainless steel frame construction, food-grade belts, upstream and downstream data links, 20-recipe storage and does not require changeover parts to move between product lines.

See video of this system in action at www.weighpack.com/primary-packaging-video-library/.

For product inquiries, visit www.weighpack.com/weighpack-sales-inquiries/.

Paxiom is the national sales, system integration and service provider for the state-of-the-art packaging machine technology manufactured by WeighPack, ValTara and EndFlex. From weighing, filling, bagging and wrapping to cartoning, tray forming, case packing and palletizing, Paxiom has delivered over 7,000 packaging solutions to over 30 countries. Customers can see these solutions in person by visiting an Xperience Center in Las Vegas, Miami, Milwaukee, Montreal, Toronto or Schio, Italy.

Contacts

David Morgan, Director of Marketing, dmorgan@weighpack.com, 702-450-0808 x625

This post was originally published on this site





Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media